Local Oncologist Aided In Clinical Investigation of Cancer Treatment, Published In Medical Journal
Highlands Oncology Group Physician Will Be Published in Cancer Chemotherapy and Pharmacology. Dr. J. Thaddeus Beck, of Highlands Oncology Group (HOG), has co-authored an investigation of an explicit treatment option for advanced cancer.
Online, September 13, 2013 (Newswire.com) - Dr. J. Thaddeus Beck, of Highlands Oncology Group (HOG), has co-authored an investigation of an explicit treatment option for advanced cancer.
The study aimed to derive the effect Panobinostat, an experimental drug for the treatment of various cancers, has on the enzyme CYP2D6. CYP2D6 is used in other cancer medications so the effect of Panobinostat on CYP2D6 is important so that they can be co-administered safely.
The research concluded that safety monitoring of sensitive CYP2D6 enzyme is recommended when co-administering with Panobinostat in future clinical practice.
"Highlands is committed to expanding access to clinical trials in our service area and is grateful to the patients that contributed to this important research," Beck said.
Cancer is a devastating disease that affects thousands of people in the United States each year.
Based on rates from 2008 to 2010, more than 40 percent of men and women born today will be diagnosed with a form of cancer at some point during their lifetime, according to National Cancer Institute. (NCI).
On January 1, 2010, in the United States there were approximately 13,027,914 men and women alive who had a history of cancer, according to the NCI.
The new treatment research will be published in the medical journal Cancer Chemotherapy and Pharmacology.
Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, according to the website of the publishing company, Springer.
HOG is dedicated to the advancement of cancer treatment in order to provide patients with the best possible care.
For more information on the journal visit: http://link.springer.com/article/10.1007/s00280-013-2237-3
Highlands Oncology Group is a state-of-the-art facility with a world-class team of specialists that is committed to providing premier cancer treatment and to enhancing the quality of life of patients and their loved one in a friendly, comfortable environment right here in Northwest Arkansas. Highlands offers the latest technology of diagnostic imaging and radiation therapies, on-site labs, a pharmacy and an infusion center. They also offer access to clinical trials, multidisciplinary clinics and support groups. Highlands Oncology Group is helping patients win the battle against cancer every day.
For more information visit www.HighlandsOncologyGroup.com.